LANCET, cilt.365, sa.9454, ss.123-129, 2005 (SCI İndekslerine Giren Dergi)
Background Treatment of HBeAg-positive patients with chronic hepatitis B is not effective in most. A combination of immunomodulatory pegylated interferon alfa-2b and antiviral lamivudine might improve the rate of sustained response.